Corcept Therapeutics
CORT
#2249
Rank
$8.57 B
Marketcap
$79.91
Share price
-2.25%
Change (1 day)
12.17%
Change (1 year)

Corcept Therapeutics (CORT) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : $0.17 Billion USD

According to Corcept Therapeutics 's latest financial reports the company's total liabilities are $0.17 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Corcept Therapeutics - Total liabilities on balance sheet (from 2003 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31$0.18 B17.32%
2024-12-31$0.16 B40.2%
2023-12-31$0.11 B40.72%
2022-12-31$81.58 M70.15%
2021-12-31$47.95 M-0.92%
2020-12-31$48.39 M17.66%
2019-12-31$41.13 M14.85%
2018-12-31$35.81 M21.11%
2017-12-31$29.56 M8.02%
2016-12-31$27.37 M-18.05%
2015-12-31$33.4 M-12.14%
2014-12-31$38.01 M-9.61%
2013-12-31$42.06 M12.49%
2012-12-31$37.38 M643.91%
2011-12-31$5.02 M30.21%
2010-12-31$3.86 M59.57%
2009-12-31$2.41 M-15.66%
2008-12-31$2.86 M-4.72%
2007-12-31$3.01 M-15.02%
2006-12-31$3.54 M-0.59%
2005-12-31$3.56 M95.34%
2004-12-31$1.82 M-95.78%
2003-12-31$43.25 M-1.1%
2002-12-31$43.73 M2221.39%
2001-12-31$1.88 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
$119.70 B 67,572.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$79.60 B 44,901.53%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$117.21 B 66,162.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$85.37 B 48,165.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$82.75 B 46,681.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$66.37 B 37,421.91%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
$0.80 B 354.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$0.81 B 360.94%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$2.37 B 1,244.82%๐Ÿ‡บ๐Ÿ‡ธ USA